108 related articles for article (PubMed ID: 14762267)
1. The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes.
von Weizsäcker F; Köck J; MacNelly S; Ren S; Blum HE; Nassal M
Methods Mol Med; 2004; 96():153-61. PubMed ID: 14762267
[No Abstract] [Full Text] [Related]
2. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.
Baumert TF; Yang C; Schürmann P; Köck J; Ziegler C; Grüllich C; Nassal M; Liang TJ; Blum HE; von Weizsäcker F
Hepatology; 2005 Feb; 41(2):247-56. PubMed ID: 15660384
[TBL] [Abstract][Full Text] [Related]
3. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus.
Köck J; Nassal M; MacNelly S; Baumert TF; Blum HE; von Weizsäcker F
J Virol; 2001 Jun; 75(11):5084-9. PubMed ID: 11333889
[TBL] [Abstract][Full Text] [Related]
4. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture.
Xu G; Gao Z; He W; Ma Y; Feng X; Cai T; Lu F; Liu L; Li W
Virology; 2014 Jan; 448():247-54. PubMed ID: 24314655
[TBL] [Abstract][Full Text] [Related]
5. Entry of hepatitis B virus: mechanism and new therapeutic target.
Xie Y; Zhai J; Deng Q; Tiollais P; Wang Y; Zhao M
Pathol Biol (Paris); 2010 Aug; 58(4):301-7. PubMed ID: 20570056
[TBL] [Abstract][Full Text] [Related]
6. Property of hepatitis B virus replication in Tupaia belangeri hepatocytes.
Sanada T; Tsukiyama-Kohara K; Yamamoto N; Ezzikouri S; Benjelloun S; Murakami S; Tanaka Y; Tateno C; Kohara M
Biochem Biophys Res Commun; 2016 Jan; 469(2):229-35. PubMed ID: 26654952
[TBL] [Abstract][Full Text] [Related]
7. [Animal model for HCV infection--chimpanzee and tupaia, etc].
Honda M; Sakai A; Kaneko S
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):126-30. PubMed ID: 15359777
[No Abstract] [Full Text] [Related]
8. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
Leistner CM; Gruen-Bernhard S; Glebe D
Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
[TBL] [Abstract][Full Text] [Related]
9. Small animal model systems for studying hepatitis B virus replication and pathogenesis.
Dandri M; Lutgehetmann M; Volz T; Petersen J
Semin Liver Dis; 2006 May; 26(2):181-91. PubMed ID: 16673296
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection is dependent on cholesterol in the viral envelope.
Bremer CM; Bung C; Kott N; Hardt M; Glebe D
Cell Microbiol; 2009 Feb; 11(2):249-60. PubMed ID: 19016777
[TBL] [Abstract][Full Text] [Related]
11. Correlation of hepatitis B core antigen and beta-catenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication.
Kim CW; Yoon SK; Jung ES; Jung CK; Jang JW; Kim MS; Lee SY; Bae SH; Choi JY; Choi SW; Han NI; Lee CD
J Gastroenterol Hepatol; 2007 Sep; 22(9):1534-42. PubMed ID: 17559383
[TBL] [Abstract][Full Text] [Related]
12. [Infection of tupaia hepatocytes with hepatitis C virus in vitro].
Zhao XP; Tian ZF; Chen YC; Yang C; Tian DY; Yang DL; Hao LJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):805-7. PubMed ID: 16313720
[TBL] [Abstract][Full Text] [Related]
13. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.
Tsuge M; Hiraga N; Takaishi H; Noguchi C; Oga H; Imamura M; Takahashi S; Iwao E; Fujimoto Y; Ochi H; Chayama K; Tateno C; Yoshizato K
Hepatology; 2005 Nov; 42(5):1046-54. PubMed ID: 16250045
[TBL] [Abstract][Full Text] [Related]
14. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
15. Duck hepatitis B virus: an invaluable model system for HBV infection.
Schultz U; Grgacic E; Nassal M
Adv Virus Res; 2004; 63():1-70. PubMed ID: 15530560
[No Abstract] [Full Text] [Related]
16. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen J; Dandri M; Mier W; Lütgehetmann M; Volz T; von Weizsäcker F; Haberkorn U; Fischer L; Pollok JM; Erbes B; Seitz S; Urban S
Nat Biotechnol; 2008 Mar; 26(3):335-41. PubMed ID: 18297057
[TBL] [Abstract][Full Text] [Related]
17. Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation.
Bagis H; Arat S; Mercan HO; Aktoprakligil D; Caner M; Turanli ET; Baysal K; Turgut G; Sekmen S; Cirakoglu B
J Exp Zool A Comp Exp Biol; 2006 May; 305(5):420-7. PubMed ID: 16489557
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors.
Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E
J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro.
Xie C; Zheng YB; Zhu HP; Peng L; Gao ZL
Cell Biol Int; 2009 Apr; 33(4):493-500. PubMed ID: 19272332
[TBL] [Abstract][Full Text] [Related]
20. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
Zhang J; Niu D; Sui J; Ching CB; Chen WN
Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
